(Q36539480)

14 August 2017

1 reference

title

Targeting adiponectin for cardioprotection (English)

1 reference

14 August 2017

Noriyuki Ouchi

1

1 reference

14 August 2017

Rei Shibata

series ordinal

2

1 reference

14 August 2017

Kenneth Walsh

series ordinal

3

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 August 2006

1 reference

Expert Opinion on Therapeutic Targets

14 August 2017

1 reference

14 August 2017

10

1 reference

14 August 2017

573-581

1 reference

14 August 2017

4

1 reference

Obesity, adiponectin and vascular inflammatory disease

14 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

Adipose tissue, inflammation, and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

AdipoQ is a novel adipose-specific gene dysregulated in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

A novel serum protein similar to C1q, produced exclusively in adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

Disturbed secretion of mutant adiponectin associated with the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

Cloning of adiponectin receptors that mediate antidiabetic metabolic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

Adiponectin and development of type 2 diabetes in the Pima Indian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

Adiponectin and protection against type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

Serum adiponectin concentrations predict the developments of type 2 diabetes and the metabolic syndrome in elderly Koreans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

Adiponectin, an adipocyte-derived protein, predicts future insulin resistance: two-year follow-up study in Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

Hypoadiponectinemia is an independent risk factor for hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

Associations among plasma adiponectin, hypertension, left ventricular diastolic function and left ventricular mass index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

Decreased plasma concentration of a novel anti-inflammatory protein--adiponectin--in hypertensive men with coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

Plasma adiponectin concentration in relation to severity of coronary atherosclerosis and cardiovascular risk factors in middle-aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

Implications of plasma concentrations of adiponectin in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

The variation of plasma concentrations of a novel, adipocyte derived protein, adiponectin, in patients with acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

Plasma adiponectin levels and risk of myocardial infarction in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

Plasma adiponectin levels are associated with insulin resistance, but do not predict future risk of coronary heart disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

Serum high molecular weight complex of adiponectin correlates better with glucose tolerance than total serum adiponectin in Indo-Asian males

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

The metabolism of isoforms of human adiponectin: studies in human subjects and in experimental animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

Diet-induced insulin resistance in mice lacking adiponectin/ACRP30

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

Disruption of adiponectin causes insulin resistance and neointimal formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

Increased beta -oxidation but no insulin resistance or glucose intolerance in mice lacking adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

The adipocyte-secreted protein Acrp30 enhances hepatic insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

Adiponectin stimulates angiogenesis in response to tissue ischemia through stimulation of amp-activated protein kinase signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

Adiponectin stimulates production of nitric oxide in vascular endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

Globular adiponectin upregulates nitric oxide production in vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

Adiponectin suppresses proliferation and superoxide generation and enhances eNOS activity in endothelial cells treated with oxidized LDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

Association of hypoadiponectinemia with impaired vasoreactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

Decreased peripheral blood flow in the pathogenesis of the metabolic syndrome comprising hypertension, hyperlipidemia, and hyperinsulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

Obesity is independently associated with coronary endothelial dysfunction in patients with normal or mildly diseased coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

Adiponectin inhibits endothelial synthesis of interleukin-8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

Adiponectin acts as an endogenous antithrombotic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

Relationship of impaired glucose tolerance to left ventricular structure and function: The Strong Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

Adiponectin-mediated modulation of hypertrophic signals in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

Exacerbation of heart failure in adiponectin-deficient mice due to impaired regulation of AMPK and glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

Role of adiponectin receptors in endothelin-induced cellular hypertrophy in cultured cardiomyocytes and their expression in infarcted heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

AMP-activated protein kinase inhibits angiotensin II-stimulated vascular smooth muscle cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

Activation of AMP-activated protein kinase inhibits protein synthesis associated with hypertrophy in the cardiac myocyte

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

Adiponectin is synthesized and secreted by human and murine cardiomyocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

AMP-activated protein kinase activates p38 mitogen-activated protein kinase by increasing recruitment of p38 MAPK to TAB1 in the ischemic heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

AMP-activated protein kinase protects cardiomyocytes against hypoxic injury through attenuation of endoplasmic reticulum stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

Discovery of a new function of cyclooxygenase (COX)-2: COX-2 is a cardioprotective protein that alleviates ischemia/reperfusion injury and mediates the late phase of preconditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

Prostaglandin E2 protects the heart from ischemia-reperfusion injury via its receptor subtype EP4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

Reduction of infarct size by selective stimulation of prostaglandin EP(3)receptors in the reperfused ischemic pig heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

Wasting as independent risk factor for mortality in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

Duality of innate stress responses in cardiac injury, repair, and remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

The inflammatory response in myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

Inflammatory cytokines and postmyocardial infarction remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

Gene therapy for myocardial angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

Postinfarction treatment with an adenoviral vector expressing hepatocyte growth factor relieves chronic left ventricular remodeling and dysfunction in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

Improvement of left ventricular remodeling and function by hydroxymethylglutaryl coenzyme a reductase inhibition with cerivastatin in rats with heart failure after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

Expression of adiponectin and its receptors in swine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

Oligomerization state-dependent activation of NF-kappa B signaling pathway by adipocyte complement-related protein of 30 kDa (Acrp30)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

Role of disulfide bonds in Acrp30/adiponectin structure and signaling specificity. Different oligomers activate different signal transduction pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

gAd-globular head domain of adiponectin increases fatty acid oxidation in newborn rabbit hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

Impaired activation of AMP-kinase and fatty acid oxidation by globular adiponectin in cultured human skeletal muscle of obese type 2 diabetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.573

10.1517/14728222.10.4.573

21 January 2018

Identifiers

DOI

1 reference

14 August 2017

1 reference